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SARA, a FYVE Domain Protein
that Recruits Smad2 to the TGFb Receptor
specific type I receptors, and the proteins are phosphor-
ylated on the last two serines at the carboxyl terminus
within a highly conserved SSXS motif (MacõÂas-Silva et
Tomoo Tsukazaki,* Theodore A. Chiang,*²
Anne F. Davison,*² Liliana Attisano,³
and Jeffrey L. Wrana*²§
*Program in Developmental Biology al., 1996; Abdollah et al., 1997; Kretzschmar et al., 1997;
Liu et al., 1997b; Souchelnytskyi et al., 1997). RegulationThe Hospital for Sick Children
Toronto, Ontario of R-Smads by the receptor kinase provides an impor-
tant level of specificity in this system. Thus, Smad2 andCanada M5G 1X8
²Department of Medical Genetics and Microbiology Smad3 are substrates of TGFb or activin receptors and
mediate signaling by these ligands (MacõÂas-Silva et al.,³Department of Anatomy and Cell Biology
University of Toronto 1996; Liu et al., 1997b; Nakao et al., 1997), whereas
Smad1, 5, and 8 are targets of BMP receptors and prop-Toronto, Ontario
Canada M5S 1A8 agate BMP signals (Hoodless et al., 1996; Chen et al.,
1997b; Kretzschmar et al., 1997; Nishimura et al., 1998).
Once phosphorylated, R-Smads associate with the com-
mon Smad, Smad4 (Lagna et al., 1996; Zhang et al.,
Summary 1997), and mediate nuclear translocation of the hetero-
meric complex. In the nucleus, Smad complexes then
Smads transmit signals from transmembrane ser/thr activate specific genes through cooperative interactions
kinase receptors to the nucleus. We now identify SARA with DNA and other DNA-binding proteins such as
(for Smad anchor for receptor activation), a FYVE do- FAST1, FAST2, and Fos/Jun (Chen et al., 1996, 1997a;
main protein that interacts directly with Smad2 and Liu et al., 1997a; LabbeÂ et al., 1998; Zhang et al., 1998;
Smad3. SARA functions to recruit Smad2 to the TGFb Zhou et al., 1998). In contrast to R-Smads and Smad4,
receptor by controlling the subcellular localization of the antagonistic Smads, Smad6 and 7, appear to func-
Smad2 and by interacting with the TGFb receptor com- tion by blocking ligand-dependent signaling (reviewed
plex. Phosphorylation of Smad2 induces dissocia- in Heldin et al., 1997).
tion from SARA with concomitant formation of Smad2/ Phosphorylation of R-Smads by the type I receptor is
Smad4 complexes and nuclear translocation. Further- essential for activating the TGFb signaling pathway (Heldin
more, mutations in SARA that cause mislocalization et al., 1997; Attisano and Wrana, 1998; Kretzschmar and
of Smad2 inhibit TGFb-dependent transcriptional re- MassagueÂ , 1998). However, little is known of how Smad
sponses, indicating that the regulation of Smad local- interaction with receptors is controlled. Here, we de-
ization is important for TGFb signaling. These results scribe the identification of a novel Smad2/Smad3 inter-
thus define SARA as a component of the TGFb path- acting protein that contains a double zinc finger, or FYVE
way that brings the Smad substrate to the receptor. domain, and which we have called SARA. We show that
SARA recruits Smad2 into distinct subcellular domains
and that SARA colocalizes and interacts with TGFb re-
Introduction ceptors. TGFb signaling induces dissociation of Smad2
from SARA with concomitant formation of Smad2/Smad4
Members of the transforming growth factor b (TGFb) complexes and nuclear translocation. Moreover, dele-
superfamily signal through a family of cell-surface trans- tion of the FYVE domain in SARA causes mislocalization
membrane serine/threonine kinases, known as type I of Smad2 and inhibits TGFb-dependent transcriptional
and type II receptors (Heldin et al., 1997; Attisano and responses. Thus, SARA defines a component of TGFb
Wrana, 1998; Kretzschmar and MassagueÂ , 1998). Ligand signaling that functions to recruit Smad2 to the receptor
induces formation of heteromeric complexes of these by controlling the subcellular localization of Smad.
receptors, and signaling is initiated when receptor I is
phosphorylated and activated by the constitutively ac-
Resultstive kinase of receptor II (Wrana et al., 1994). The acti-
vated type I receptor kinase then propagates the signal
Identification of SARAto a family of intracellular signaling mediators known as
Smad2 is a critical intracellular mediator of the TGFbSmads.
signaling pathway (Heldin et al., 1997; Attisano andThree classes of Smads with distinct functions have
Wrana, 1998; Kretzschmar and MassagueÂ , 1998). Thus,been defined: the receptor-regulated Smads, which in-
to define additional components of this pathway, weclude Smad1, 2, 3, 5, and 8; the common mediator Smad,
initiated a screen to identify Smad2 partners. For this,Smad4; and the antagonistic Smads, which include
the MH2 domain of Smad2 was fused to glutathione-S-Smad6 and 7 (Heldin et al., 1997; Attisano and Wrana,
transferase (GST) that included a kinase recognition site1998; Kretzschmar and MassagueÂ , 1998). Receptor-reg-
for protein kinase A (PKA). The bacterially expressedulated Smads (R-Smads) act as direct substrates of
fusion protein was labeled to high specific activity using
PKA (Chen and Sudol, 1995) and then used to screen
a lZAPII expression library prepared from the dorsal§ To whom correspondence should be addressed (e-mail: jwrana@
sickkids.on.ca). blastopore lip of Xenopus. This yielded repeated isolates
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Figure 1. SARA Defines a Class of Conserved Proteins
(A) Comparison of the amino acid sequence of Xenopus and human SARA. Identical (dark gray) and conserved residues (light gray), the FYVE
domain (solid underline), and the Smad-binding domain (dashed underline) are indicated. Sequences in XSARA used to design degenerate
PCR primers for identifying hSARA are shown (arrows). The amino-terminal end of the partial Xenopus cDNA obtained in the expression
screen is marked (asterisk).
(B) Alignment of the amino acid sequences of the FYVE domains from human and Xenopus SARA, KIAA0305, FGD1, Hrs-1, Hrs-2, and EEA1.
Identical residues (dark gray) and conservative changes (light gray) are marked. A consensus sequence (bottom) was derived from positions
in which at least six out of seven residues were conserved or when proteins contained one of only two alternate residues.
of a partial cDNA clone. To obtain the entire coding protein of 1235 amino acids with an estimated molecular
mass of 135 kDa (Figure 1A). Based on our subsequentsequence, we probed the blastopore lip library with the
partial cDNA clone and performed 59 RACE. Analysis functional analysis, we have called this cDNA XSARA,
for Xenopus Smad anchor for receptor activation.of the complete cDNA sequence revealed a predicted
Regulation of Smad Localization
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To investigate the role of this protein in TGFb signaling
in mammalian cells, we identified a human homolog
using a combination of degenerate RT-PCR and screen-
ing of a human brain cDNA library. Analysis of the contig-
uous sequence revealed a long open reading frame that
encoded a predicted protein of 1323 amino acids with
a consensus start codon preceded by stop codons in
all three reading frames. Comparison of this sequence
with that from XSARA (Figure 1A) revealed an overall
identity of 62% with a divergent 558-residue amino ter-
minal domain (35% identity) followed by a closely related
carboxy-terminal domain (85% identity). Given this se-
quence similarity and subsequent functional analysis,
we designate this clone hSARA, for human SARA.
Sequence analysis of SARA (Figure 1A) revealed a
region in the middle portion of the predicted protein that
had similarity to a double zinc finger domain or FYVE
domain. The FYVE domain has been identified in a num-
ber of unrelated signaling molecules that include FGD1,
a putative guanine exchange factor for Rho/Rac that
is mutated in faciogenital dysplasia; the HGF receptor
substrate Hrs-1 and its homolog, Hrs-2; EEA1, a protein
involved in formation of the early endosome; and the
yeast proteins FAB1, VPS27, and VAC1 (reviewed in
Wiedemann and Cockcroft, 1998). Recently, analysis of
a number of FYVE domains from yeast and mammals
has revealed that this motif binds phosphatidyl inositol-
3-phosphate (PtdIns(3)P) with high specificity and thus
represents a novel signaling module that can mediate
protein interaction with membranes (Burd and Emr,
1998; Gaullier et al., 1998; Patki et al., 1998; Simonsen
et al., 1998; Wiedemann and Cockcroft, 1998). Compari-
son of the FYVE domains from the vertebrate proteins
with that from SARA revealed extensive conservation of
residues throughout the domain (Figure 1B). Thus, SARA
contains a FYVE domain that may function to bind
PtdIns(3)P.
Analysis of the expression pattern of hSARA revealed
that the gene was expressed in all adult tissues exam-
ined, similar to Smad2 (Figure 2A). Further analysis in a
variety of cell lines by RT-PCR revealed that SARA was
expressed in every cell line tested, including HepG2Figure 2. Interaction and Expression Patterns of hSARA and Smad2
hepatoma cells, NBFL neuroblastoma cells, SW480 co-(A) hSARA and Smad2 are ubiquitously expressed in similar patterns.
An ApaI-SmaI restriction fragment from the 39UTR of hSARA (top lorectal cancer cells, NIH 3T3 fibroblasts, P19 embryonic
panel) and a Smad2 MH1 domain cDNA fragment (bottom panel) carcinoma cells, MC3T3 calvarial cells, and Mv1Lu lung
were used to probe a human multiple tissue Northern blot (Clontech). epithelial cells (data not shown). Thus, we conclude that
A single transcript of approximately 5.0 kb, corresponding to the
SARA is a ubiquitously expressed partner for Smad2.full-length hSARA cDNA, is indicated.
(B) In vitro interaction of hSARA with bacterially expressed Smads.
hSARA Interacts Specifically with Smad2Full-length [35S]methionine-labeled SARA produced by in vitro tran-
scription/translation was incubated with sepharose-bound bacteri- and Smad3
ally expressed Smads or Smad2 subdomains, and bound material To characterize the interaction of hSARA with Smads,
was visualized by SDS-PAGE and autoradiography. Migration of we translated the full-length protein in vitro and tested
full-length hSARA and a translation product that initiates from an
for binding to bacterially expressed Smad fusion pro-internal methionine (asterisk) are indicated. GST fusion protein con-
teins. hSARA bound specifically to full-length Smad2centrations were determined by Coomassie staining of a protein
aliquot (bottom panel).
(C) Interaction of hSARA with Smads in mammalian cells. COS cells
were transfected with Flag-tagged hSARA (Flag-SARA) either alone cell lysates were immunoblotted with the anti-Flag and anti-Myc
or together with the indicated Myc-tagged Smad constructs. For antibodies (bottom panel).
Smad6, an alternative version lacking the MH1 domain was used (D) Interaction of endogenous SARA and Smad2 in mammalian cells.
(Topper et al., 1997). Cell lysates were subjected to an anti-Flag Lysates from HepG2 cells, either untreated or treated for 30 min with
immunoprecipitation, and coprecipitating Smads were detected by 1 nM TGFb as indicated, were immunoprecipitated with preimmune
immunoblotting with anti-Myc antibodies. The migration of anti-Flag sera, affinity-purified anti-SARA antibody, or N19 anti-Smad2/3 anti-
heavy and light chains (IgH and IgL, respectively) are marked. To body. Coprecipitating Smad2 was detected by immunoblotting with
confirm efficient expression of hSARA and Smads, aliquots of total a polyclonal anti-Smad2 antibody (MacõÂas-Silva et al., 1998).
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and the highly related Smad3, but not Smad1 or Smad4
(Figure 2B). To define the domains of Smad2 that bound
hSARA, various fragments of Smad2 corresponding to
the MH1 domain, linker region, and MH2 domain were
expressed in bacteria. hSARA interacted efficiently with
fusion proteins that comprised the MH2 domain, while
no association was detected between hSARA and either
the MH1 or nonconserved linker domains (Figure 2B).
Similar findings were obtained with Xenopus SARA (data
not shown). Thus, SARA interacts with Smad2 through
the MH2 domain.
To confirm that hSARA also bound to Smads in mam-
malian cells, we expressed a Flag epitope±tagged ver-
sion of SARA in COS-1 cells together with Myc-tagged
versions of Smads 1, 2, 3, 4, 6, and 7. Cell lysates were
subjected to anti-Flag immunoprecipitation followed by
immunoblotting with anti-Myc antibodies. In immuno-
precipitates of cells expressing either Smad2 or Smad3,
efficient coprecipitation of either Smad with Flag-SARA
was observed (Figure 2C). In contrast, none of the other
Smads coprecipitated with SARA. Specific binding of
SARA to both Smad2 and Smad3 is consistent with
the observation that these two proteins possess very
closely related MH2 domains (97% identity) and are both
activated by TGFb or activin type I receptors (MacõÂas-
Silva et al., 1996; Liu et al., 1997b; Nakao et al., 1997).
We also tested for interaction between endogenous
SARA and Smad2. For this, SARA was immunoprecipi-
tated from HepG2 cells using an affinity-purified anti-
SARA polyclonal antibody, and Smad2 was visualized
by immunoblotting with anti-Smad2 antibody (MacõÂas-
Silva et al., 1998). In immunoprecipitates prepared with
preimmune antisera, no Smad2 was detectable (Figure
2D). However, in the anti-SARA immunoprecipitates, we
could clearly detect Smad2 coprecipitating with SARA.
Interestingly, TGFb treatment prior to lysis revealed
decreased association of Smad2 with SARA. Together,
these results demonstrate that SARA is a specific part-
ner for receptor-regulated Smads in the TGFb/activin
Figure 3. Effects of TGFb Signaling on SARA and Formation of
signaling pathway and further suggest that TGFb signal- SARA/Smad2 Complexes
ing induces dissociation of SARA/Smad2 complexes.
COS cells were transiently transfected with various combinations
of Flag or Myc-tagged hSARA; wild-type (WT) or mutant (2SA) Myc or
Phosphorylation of Smad2 Induces Flag-tagged Smad2; Smad4/HA; and wild type (WT) or constitutively
active (A) TbRI/HA. Cell lysates were then subjected to immunopre-Dissociation from SARA
cipitation with anti-Flag or anti-Myc antibodies, as indicated. Confir-Activation of TGFb signaling results in phosphorylation
mation of protein expression was performed by immunoblottingof Smad2 or Smad3 by type I receptors on C-terminal
total cell lysates prepared in parallel for the indicated tagged proteinserine residues (MacõÂas-Silva et al., 1996; Liu et al.,
(totals, bottom panels).
1997b; Souchelnytskyi et al., 1997). Thus, we investi- (A) Phosphorylation of SARA is not regulated by TGFb signaling.
gated whether receptor-mediated phosphorylation of Transfected cells were labeled with [32P]PO4, and lysates were sub-
Smad2 or SARA might regulate their interaction. For jected to immunoprecipitation with anti-Flag antibodies for visual-
ization of hSARA phosphorylation (top panel) or with anti-Myc anti-this, we used a constitutively active TGFb type I receptor
bodies for Smad2 phosphorylation (middle panel).that regulates phosphorylation and activation of Smad
(B) Activation of TGFb signaling induces dissociation of SARA/proteins in a manner similar to ligand (Hoodless et al.,
Smad2 complexes. Lysates from transiently transfected cells were
1996; MacõÂas-Silva et al., 1996). COS cells transfected subjected to immunoprecipitation with anti-Flag antibodies, and
with combinations of Smad2, SARA, and receptor were Smad2 bound to SARA was analyzed by immunoblotting with anti-
metabolically labeled with [32P]phosphate, and phos- Myc antibodies (IP, a-flag; blot, a-Myc).
(C) SARA/Smad2 and Smad2/Smad4 complexes are mutually exclu-phorylation of either SARA or Smad2 was assessed in
sive. Cell lysates from transiently transfected cells were subjectedimmunoprecipitates. Analysis of SARA revealed that
to immunoprecipitation with anti-Flag antibodies directed towardcoexpression of the activated type I receptor did not
Smad2 and then immunoblotted using anti-Myc or anti-HA antibod-appreciably affect the overall phosphorylation (Figure ies that recognize hSARA (a-myc blot) or Smad4 (a-HA blot), respec-
3A). In contrast, the activated type I receptor induced tively.
strong phosphorylation of Smad2 as described pre-
viously (MacõÂas-Silva et al., 1996). Interestingly, unlike
Regulation of Smad Localization
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the strong induction of Smad2 phosphorylation in the In these cells, the distribution of SARA was indistin-
guishable from cells transfected with SARA alone (Fig-total cellular pool, phosphorylation of Smad2 associated
with SARA appeared to decrease in the presence of ure 4D, panel i). In contrast, the localization of Smad2
in the presence of SARA displayed a dramatic shift toTGFb signaling (Figure 3A). This suggested that recep-
tor-dependent phosphorylation of Smad2 might induce a punctate pattern (compare Figure 4B to 4D, panel ii).
Moreover, analysis of these immunofluorescent stainingdissociation from SARA. To examine this directly, we
analyzed SARA interaction with wild-type Smad2 or a patterns by confocal microscopy revealed that SARA
and Smad2 precisely colocalized in the cytosol (yellowmutant version lacking the C-terminal phosphorylation
sites (Smad2(2SA)). In the absence of TGFb signaling, stain, Figure 4D, panel iii). Interestingly, expression of
Smad2 at much higher levels than SARA reverted theassociation of SARA with either Smad2 or Smad2(2SA)
was comparable (Figure 3B). In contrast, in cells coex- distribution of Smad2 to that observed in cells trans-
fected with Smad2 alone (data not shown). This supportspressing the activated receptor, we observed a signifi-
cant decrease in the interaction of wild-type Smad2 with the notion that elevating the amount of Smad2 can satu-
rate SARA and yield a diffuse distribution of Smad2SARA, while SARA/Smad2(2SA) complexes were not
reduced. Together, these results suggest that SARA is throughout the cell.
Since phosphorylation of Smad2 results in dissocia-not phosphorylated in response to TGFb signaling and
that it preferentially interacts with the unphosphorylated tion from SARA, we investigated whether activation of
TGFb signaling induces nuclear translocation of Smad2form of Smad2.
in the presence of SARA. As shown in Figure 4, the lo-
calization of SARA in the cytosolic compartment looked
SARA and Smad4 Form Mutually Exclusive similar in the presence or absence of the constitutively
Complexes with Smad2 active TGFb type I receptor (compare Figures 4D and 4E,
Phosphorylation of Smad2 induces its interaction with panels i). However, TGFb signaling caused a significant
Smad4 (Lagna et al., 1996; Zhang et al., 1997). Since proportion of Smad2 to translocate to the nucleus (Fig-
Smad2 also interacts with SARA, we examined the for- ure 4E, panel ii), and this correlated with a shift to an
mation of Smad2/Smad4 and Smad2/SARA complexes orange-red color in the cytosolic colocalization stain
in the same transfectants in response to TGFb signaling. (Figure 4E, panel iii). Thus, activation of TGFb signaling
For this, lysates from transiently transfected COS cells induces Smad2 to dissociate from SARA and translocate
were subjected to immunoprecipitation with anti-Flag to the nucleus.
antibodies directed toward tagged Smad2 followed by To confirm that the punctate localization of overex-
immunoblotting for the presence of Smad4 and SARA. pressed SARA reflected that of the endogenous protein,
Consistent with previous findings (Lagna et al., 1996; we examined SARA and Smad2 in Mv1Lu cells. Analysis
Zhang et al., 1997), interaction of Smad4 with Smad2 of the distribution of endogenous SARA using rabbit
was strongly stimulated by the activated type I receptor anti-SARA antibodies revealed a punctate distribution
(Figure 3C, lane 3 and 4). Concomitant with this, the similar to that observed for transiently transfected, epi-
interaction of Smad2 with SARA was disrupted (Figure tope-tagged SARA (Figure 4F, panel i). This staining was
3C, lanes 6 and 7). Furthermore, we never observed specific, since cells stained with preimmune antisera or
association of SARA and Smad4 in the presence of TGFb purified antibody blocked with the SARA antigen re-
signaling (data not shown). Thus, complexes of Smad2/ vealed no detectable staining in the cytosol (data not
SARA and Smad2/Smad4 are mutually exclusive. To- shown). Examination of endogenous Smad2 distribution
gether these results demonstrate that during TGFb sig- in the same cell revealed a punctate distribution for
naling, phosphorylation of Smad2 induces its dissocia- Smad2 (Figure 4F, panel ii) as published previously (Jan-
tion from SARA and promotes formation of heteromeric knecht et al., 1998). Furthermore, analysis of SARA and
complexes with Smad4. Smad2 together revealed extensive colocalization of the
two proteins (Figure 4F, panel iii). Colocalization was
not complete and may reflect differences in the stoichi-
SARA Regulates the Subcellular ometry of SARA versus Smad2 protein levels, as sug-
Localization of Smad2 gested above, or the presence of additional regulatory
Our biochemical analyses of SARA/Smad2 interactions mechanisms that control interaction of the endogenous
suggested that SARA functions upstream in the pathway proteins. Taken together with our biochemical analysis,
and might control the subcellular localization of Smad2. these results indicate that SARA functions to recruit
To test this we investigated whether coexpression of Smad2 to specific subcellular regions in the cell prior
SARA might alter the localization of Smad2 in the TGFb- to activation by TGFb signaling.
responsive epithelial cell line, Mv1Lu, using confocal
microscopy. In cells expressing SARA alone, the protein
displayed a punctate staining pattern that was present SARA Colocalizes with TbRII
The positioning of SARA upstream of Smad2 activationthroughout the cytosolic compartment and was ex-
cluded from the nucleus (Figure 4A). This localization of suggested to us that SARA might recruit Smad2 to spe-
cific subcellular domains for phosphorylation and acti-SARA was in contrast to the diffuse staining typically
observed for Smad2 in cells overexpressing the protein vation by the receptor. Interestingly, previous studies
on the TGFb receptor demonstrated clustering of the(Figure 4B). Since excess Smad2 expression might over-
whelm endogenous SARA protein, we next examined receptor complex into punctate domains that resembled
those displayed by SARA (Henis et al., 1994; Gilboa etcells transiently transfected with both SARA and Smad2.
Cell
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Figure 4. SARA Regulates the Localization of
Smad2
(A±E) Mv1Lu cells were transiently trans-
fected with hSARA alone (A), Smad2 alone
(B), Smad2 with constitutively active TbRI
(TbRI*, [C]), or Flag-Smad2 with Myc-hSARA
with (E) or without (D) constitutively active
TbRI as indicated (Tx). hSARA was visualized
with the polyclonal Myc A14 antibody, and
Texas red±conjugated goat anti-rabbit IgG
(red) and Smad2 was detected with an anti-
Flag M2 monoclonal antibody followed by
FITC-conjugated goat anti-mouse IgG (green).
The subcellular localization of the expressed
proteins was visualized by immunofluores-
cence and confocal microscopy. Colocaliza-
tion of SARA and Smad2 appears as yellow.
(F) Colocalization of endogenous SARA and
Smad2/3. Endogenous SARA in Mv1Lu cells
was visualized with polyclonal rabbit anti-
SARA antibody (panel i, green), and Smad2/3
was visualized with the polyclonal goat anti-
Smad2/3 N19 antibody (Santa Cruz) (panel ii,
red). Colocalization of SARA and Smad2 is
shown (panel iii) and appears as yellow.
al., 1998). Thus, to test whether SARA might colocal- whether SARA might interact with the receptors. As de-
scribed previously for Smad2 (MacõÂas-Silva et al., 1996),ize with TGFb receptors, Mv1Lu cells transfected with
SARA and TGFb receptors were treated with TGFb, and COS cells were cotransfected with TGFb receptors in
the presence of SARA and then affinity labeled usingprotein subcellular localization was determined. As ob-
served previously (Henis et al., 1994; Gilboa et al., 1998), [125I]TGFb. SARA was immunoprecipitated from the cell
lysates, and coprecipitating receptor complexes wereTbRII displayed a punctate staining pattern similar to
the SARA pattern (Figure 5A, panels i and ii). Further, in visualized by autoradiography or quantitated using a
gamma counter. Analysis of cells expressing wild-typecells coexpressing SARA and TGFb receptors, extensive
colocalization of the proteins was observed (Figure 5A, receptors revealed that these complexes coprecipitated
with SARA (Figure 5B, lane 3). Furthermore, in the pres-panel iii). This colocalization was not complete, possibly
reflecting a restricted distribution of SARA to only a ence of kinase-deficient type I receptor, there was a
small increase in binding of SARA to the receptor (Figuresubset of the intracellular compartments normally occu-
pied by transmembrane receptors, which include the 5B, lane 2). This is in contrast to Smad2 that only inter-
acts with TGFb receptor complexes that contain kinase-endoplasmic reticulum, Golgi, and endocytic compart-
ments. Thus, SARA and the TGFb receptors colocalize deficient type I receptors (MacõÂas-Silva et al., 1996).
These data suggest that SARA associates with the TGFbto common subcellular domains.
Since SARA and TGFb receptors colocalize, we tested receptor.
Regulation of Smad Localization
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We next examined whether coexpression of Smad2
might enhance the interaction of SARA with TGFb recep-
tors. In cells expressing wild-type receptor I, we ob-
served no difference in the amount of receptor complexes
that coprecipitated with SARA either in the presence or
absence of Smad2 (Figure 5B, compare lanes 3 and
5). In contrast, the association of SARA with receptor
complexes containing kinase-deficient type I receptors
was enhanced by Smad2 (Figure 5B, lane 4). This finding
was consistent with our previous demonstration that
kinase-deficient type I receptors stabilize interactions
of Smad2 with the receptors (MacõÂas-Silva et al., 1996).
To investigate further the requirement for Smad2 in the
interaction of SARA with the receptor, we also tested a
mutant of SARA, SARA(DSBD), that removes the Smad-
binding domain (see below). Analysis of SARA interac-
tion with receptor complexes containing kinase-defi-
cient TbRI showed that wild-type SARA interacted with
the receptor, and this was enhanced approximately
2-fold by Smad2 (Figure 5C). The DSBD mutant of SARA
retained the capacity to associate with the receptor,
although the efficiency of interaction was slightly re-
duced relative to wild-type SARA. Importantly, unlike
wild-type SARA, binding of mutant SARA to the receptor
was not enhanced by coexpression of Smad2. Together,
these data suggest that SARA interacts with the TGFb
receptor independently of Smad2 binding and that
Smad2 cooperates to enhance association.
A Modular Domain in SARA Mediates
Association with Smads
To investigate the functional importance of SARA in
TGFb signaling, we defined the domains in the protein
that mediate its interaction with Smad2, its localization
to specific subcellular regions, and its association with
the TGFb receptor. To this end, we constructed a series
of deletion mutants of SARA and first tested their ability
to interact with Smad2 in COS cells by immunoprecipita-
tion followed by immunoblotting. As summarized in Fig-
ure 6A, loss of the first 664 amino acids of SARA, which
included the double zinc finger/FYVE domain, did not
interfere with SARA binding to Smad2, while further de-
letions (D1±704) completely abolished the interaction. A
similar analysis of C-terminal truncations revealed that
deletion of residues upstream of position 749 (D665±Figure 5. SARA Interacts with Receptor Complexes
1323) completely abrogated binding to Smad2. To deter-(A) Mv1Lu cells were transfected with either hSARA alone (panel i),
mine whether the region defined by this deletional analy-TbRII alone (panel ii), or SARA and TbRII together (panel iii). Cells
were then treated with TGFb, and the localization of hSARA (red) and sis was sufficient to bind Smad2, we linked the 85 amino
TbRII (green) was determined by immunofluorescence and confocal acids we refer to as the Smad-binding domain (SBD) to
microscopy. Colocalization of SARA and TbRII appears as yellow GST and expressed the fusion protein in bacteria (GST-
(panel iii). hSARA[665±750]). Incubation of lysates prepared from
(B) SARA interacts with the TGFb receptor. COS cells were tran-
cells expressing Smad2 or Smad3 with GST-SBD re-siently transfected with various combinations of Flag-hSARA, Myc-
sulted in efficient binding of both Smads to the fusionSmad2, wild type (WT) TbRII, and either wild-type or kinase-deficient
protein (Figure 6B). This interaction is likely direct, since(KR) versions of TbRI. Cells were affinity labeled with [125I]TGFb and
lysates immunoprecipitated with anti-Flag antibodies. Coprecipitat- bacterially expressed SBD associates efficiently with
ing receptor complexes were visualized by SDS-PAGE and autoradi- bacterially produced Smad2 (data not shown). These
ography. Equivalent receptor expression was confirmed by visualiz- studies thus define a novel domain in SARA that medi-
ing aliquots of total cell lysates (bottom panel). ates interaction with Smad2 and Smad3 and which is(C) Smad2 binding to SARA enhances receptor interaction. COS
located downstream of the FYVE domain.cells were transiently transfected with wild-type TbRII and kinase-
deficient TbRI and various combinations of wild-type Flag-hSARA
(WT), a mutant version lacking the Smad2-binding domain (DSBD)
and Myc-Smad2. The amount of receptor bound to SARA was deter- Protein expression was analyzed by immunoblotting aliquots of total
mined by anti-Flag immunoprecipitation followed by gamma count- cell lysates, and the results from a representative experiment are
ing. Data are plotted as the average of three experiments 6 SD. shown (bottom panel).
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Figure 6. Mapping the Functional Domains on SARA
(A) Schematic representation of mutant versions of SARA. The FYVE domain (black bar) and the Smad-binding domain (SBD; striped bar) are
indicated. COS cells transiently transfected with Flag-hSARA and Myc-Smad2 were immunoprecipitated with anti-Flag antibodies followed
by immunoblotting with anti-Myc antibodies. The presence (1) or absence (2) of a SARA/Smad2 interaction is indicated (Smad2 interaction).
Mutants used for the subsequent localization study are marked on the left (i±viii).
(B) The Smad-binding domain (SBD) of SARA is sufficient for interaction with Smad2 and Smad3. Lysates from COS cells expressing Flag-
tagged Smad2 or Smad3 were incubated with GST alone or with GST-hSARA (665±750), which corresponds to the SBD, and bound proteins
were immunoblotted using anti-Flag antibodies. The presence of Smad2 and Smad3 bound to GST-hSARA(665±750) is indicated.
(C) The Smad-binding domain (SBD) of SARA binds preferentially to unphosphorylated Smad2. Lysates from COS cells expressing Flag-
tagged Smad2 together with wild-type (WT) or activated (A) type I receptor were incubated with GST-hSARA(665±750) (GST-SBD), and bound
Smad2 was immunoblotted using anti-Flag antibodies. Note that Smad2 from cell lysates cotransfected with the activated type I receptor
display reduced interaction with GST-SBD. The expression levels of Smad2, each receptor, and GST-hSARA(665±750) are indicated.
(D) Subcellular localization of SARA mutants. Mv1Lu cells were transiently transfected with wild-type (panel i) or mutant versions of Flag-
hSARA (panels ii±viii, as marked on the left in [A]). Proteins were visualized by immunofluorescence and confocal microscopy using a monoclonal
anti-Flag M2 monoclonal antibody followed by FITC-conjugated goat anti-mouse IgG.
(E) Identification of receptor-binding domain of SARA. COS cells were transiently transfected with wild-type TbRII and kinase-deficient TbRI
and Flag-tagged wild-type (WT) or mutant versions of SARA with (black bars) or without (open bars) Myc-Smad2. The amount of receptor
bound to SARA was determined by anti-Flag immunoprecipitation followed by gamma counting (as in Figure 5). Protein expression was
analyzed by immunoblotting aliquots of total cell lysates (bottom panel).
Our previous analysis showed that activation of Smad2 Consistent with our previous observations, phosphory-
lation of Smad2 by activated TbRI strongly reduced in-by the TGFb receptor induced dissociation from SARA.
To determine whether this reflects an alteration in the teractions with GST-SBD (Figure 6C). This correlated
with receptor-dependent phosphorylation, since theability of the SBD to bind phosphorylated Smad2, we
tested the interaction of GST-SBD with Smad2 in lysates phosphorylation site mutant, Smad2(2SA), interacted ef-
ficiently with GST-SBD, even in the presence of acti-obtained from cells expressing Smad2 alone or together
with either wild-type or activated TGFb type I receptor. vated TbRI (data not shown). Together with our previous
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results, these data strongly support the notion that receptor interaction, even in the absence of appropriate
localization signals.SARA interacts with unphosphorylated Smad2 and that
receptor-dependent phosphorylation induces dissocia- Together, these data define discrete domains in SARA
that fulfill specific aspects of SARA function in TGFbtion by altering the affinity of Smad2 for the SBD.
signaling. The FYVE domain likely functions to direct
SARA to the membrane and by analogy with other FYVEThe FYVE Domain Controls the Subcellular
domain proteins, may do so through interactions withLocalization of SARA
PtIns(3)P (Wiedemann and Cockcroft, 1998). It thus ful-We next analyzed the subcellular localization of a selec-
fills an important role in recruiting SARA to specific sub-tion of our SARA mutants by immunofluorescence and
cellular domains that we show also contain the TGFbconfocal microscopy. Analysis of truncation mutants
receptor. The SBD in turn functions to bind unactivatedthat removed the amino terminus upstream of the FYVE
Smad2, thus recruiting the receptor substrate to thisdomain (D1±531) yielded wild-type patterns of staining
subcellular region. Once localized to this region, the(Figure 6D, compare panels i and ii). However, further
C-terminal domain of SARA functions with Smad2 bounddeletions that remove the conserved amino-terminal
to the SBD to promote interaction with the receptorportion (D1±594) or the entire FYVE domain (D1±664,
complex. These three domains thus function coopera-
D1±704) abolished the wild-type staining pattern (Figure
tively to recruit Smad2 to the TGFb receptor.6D, panels iii±v) even in the presence of an intact Smad-
binding domain (D1±594, D1±664; Figure 6D, panels iii
and iv). Similar studies of the C-terminal domain mutants SARA-Mediated Localization of Smad2
showed that deletion of residues downstream of the Is Necessary for TGFb Signaling
FYVE domain (D665±1323) did not alter the localization The availability of mutants of SARA that interact with
of the mutant protein (Figure 6D, panel vi), while trunca- Smad2 but fail to target to the appropriate subcellular
tions to within the FYVE domain (D596±1323) led to dif- sites allowed us to address the question of whether
fuse localization throughout the cell (Figure 6D, panel SARA-mediated localization of Smad2 was important in
vii). Of note, the D665±1323 mutant that lacks the Smad- TGFb signaling. We first tested whether SARA (D1±594)
binding domain had a wild-type staining pattern, thereby and SARA (D1±664), which bind Smad but fail to distrib-
indicating that interaction with Smad2 is not required for ute to the correct subcellular domains, would mislocal-
proper SARA localization. To confirm that FYVE domain ize Smad2. Coexpression of either mutant with Smad2
function was required for localization of SARA, we also showed that they were unable to recruit Smad2 to the
tested a mutant with a small internal deletion that re- normal SARA domains (Figure 7A, panel i and ii). As ex-
moves the FYVE domain (D597±664). Consistent with pected, SARA(D1±704), which lacks a Smad-binding do-
our other mutants, localization of this protein was clearly main, was unable to control Smad2 localization (Figure
disrupted (Figure 6D, panel viii). Thus, we conclude that 7A, panel iii). We also examined directly whether these
the FYVE domain is required to maintain the normal mutants could cause mislocalization of Smad2. For this,
localization of SARA but is not involved in mediating cells were cotransfected with wild-type SARA and Smad2
interaction with Smads. either in the absence or presence of SARA(D1±594),
SARA(D1±664), or SARA(D1±704). In control transfec-
tants performed in the absence of mutant SARA, SARAThe C-Terminal Domain of SARA Interacts
with the TGFb Receptor and Smad2 were colocalized in punctate domains as
described above (Figure 7B, panel i). However, in theTo characterize the domains in SARA that mediate bind-
ing to the TGFb receptor, we tested the interaction of presence of either SARA(D1±594) or SARA(D1±664), the
localization of wild-type SARA was normal, but the distri-our panel of SARA mutants with the TGFb receptor.
Interestingly, interaction with the TGFb receptor was bution of Smad2 was clearly disrupted and displayed a
diffuse pattern (Figure 7B, panels ii and iii, respectively).strongly suppressed but not abolished in three mutants
in which the FYVE domain was disrupted (Figure 6E; Moreover, coexpression of SARA(D1±704), which does
not bind Smad2, resulted in Smad2 distribution that wasD1±594, D1±664, and the internal deletion D597±664).
Since the FYVE domain is required for the correct sub- indistinguishable from that of the wild-type pattern (Fig-
ure 7B, panel iv). Thus, SARA(D1±594) and SARA(D1±cellular localization of SARA, we reasoned that once
bound to the membrane, other regions in SARA might 664) induce the mislocalization of Smad2.
Since SARA(D1±664) mislocalizes Smads and inter-contribute to the interaction with the receptor. To exam-
ine this possibility, we tested several carboxy-terminal feres with receptor association, we investigated whether
this mutant would disrupt TGFb signaling. To test this,truncation mutants. Interestingly, deletion of the C termi-
nus downstream of position 750 suppressed receptor we transiently transfected the TGFb-responsive reporter
gene 3TP-lux into Mv1Lu cells in the presence and ab-interaction, despite efficient expression of the truncated
protein. This suggests that regions in the carboxyl termi- sence of wild-type or mutant versions of SARA. Expres-
sion of wild-type SARA had no effect on TGFb signalingnus of SARA contribute to receptor interaction. In these
analyses we also explored whether overexpression of (Figure 7C). In contrast, transfection of SARA(D1±664)
significantly inhibited TGFb-dependent signaling at theSmad2 could rescue interaction of SARA mutants with
the receptor. For both the FYVE domain mutants and lowest concentration of DNA tested, while transfection
of higher doses completely abolished responsivenessthe C-terminal truncation, Smad2 expression was able
to restore some interaction with the TGFb receptor. It of the cells. We also tested SARA(D1±704), which lacks
a functional Smad-binding domain and does not alteris likely that the high levels of protein and receptor ex-
pression that are achieved in COS cells can drive some Smad2 localization. Transfection of this mutant had no
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788
Figure 7. Mislocalization of Smad2 by SARA Mutants Blocks TGFb Signaling
(A and B) SARA mutants lacking the FYVE domain mislocalize Smad2. Mv1Lu cells were transiently transfected with mutant versions of Myc-
hSARA and Flag-Smad2 (A) or with wild-type Myc-hSARA, HA-Smad2, and mutant versions of hSARA (B) as indicated. Protein subcellular
localization was visualized by immunofluorescence and confocal microscopy. hSARA was visualized with the polyclonal Myc A14 antibody
and FITC-conjugated goat anti-rabbit IgG (green), while Smad2 was detected with monoclonal antibodies followed by Texas red±conjugated
goat anti-mouse IgG (red). In (B), overlaying the images reveals mislocalization of Smad2 as green speckles of SARA over red, diffuse Smad2
staining (panels ii and iii), and colocalization of SARA and Smad2 appears as yellow spots (panels i and iv).
(C and D) FYVE domain mutants of SARA block TGFb-dependent activation of transcription. (C) Mv1Lu cells were transfected with 3TP-lux
alone or together with the indicated amounts of wild-type (WT) or mutant (D1±664 or D1±704) versions of hSARA. (D) HepG2 cells were
transfected with ARE-Lux alone (v), or ARE-Lux and FAST2 alone or together with the indicated amounts of wild-type (WT) or mutant versions
of SARA. Transfected cells were incubated in the presence (black bars) or absence (open bars) of TGFb, and luciferase activity was normalized
to b-galactosidase activity and is plotted as the mean 6 SD of triplicates from a representative experiment.
(E) A model for SARA function in TGFb signaling. See discussion for details.
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effect on TGFb signaling (Figure 7C). In addition to its own SARA may interact inefficiently with the complex.
Thus, the primary mechanism for SARA recruitment ofanalysis of the 3TP promoter, we examined induction
of the activin response element (ARE) from the Xenopus Smad2 to the receptor is likely through its ability to
regulate Smad2 localization.Mix.2 gene in HepG2 cells. This ARE is stimulated by
either TGFb or activin signaling, which induces assem- What feature of the TGFb pathway might define a
requirement for recruiting receptor-regulated Smads tobly of a DNA-binding complex that is composed of
Smad2, Smad4, and a member of the FAST family of fork- specific subcellular domains? In intact cells, receptor-
regulated Smads are cytosolic proteins that require ac-head DNA-binding proteins. Since HepG2 cells do not
possess endogenous FAST activity, we cotransfected tivation by transmembrane serine/threonine kinase re-
ceptors. Consequently, recruitment of Smads may bewild-type or mutants of SARA, together with FAST2 and
the ARE-lux reporter plasmid as described previously required to facilitate interaction with the TGFb receptor.
Consistent with this, we observed that the domains in(LabbeÂ et al., 1998). Expression of either SARA(1-D594)
or SARA(1-D664), which interfere with normal Smad2 which SARA is found correspond to regions where the
receptors are also localized. Thus, TGFb receptors dis-localization, resulted in a strong suppression of TGFb-
dependent induction of the ARE (Figure 7D). However, play regionalized localization, and SARA recruits Smad2
to these domains. The identity of these intracellular do-none of the other mutants that we tested suppressed
activation of this promoter. Since none of these latter mains is still under investigation. However, PtdIns(3)P
binding by FYVE fingers is conserved in yeast and mam-mutants disturb the localization of SARA±Smad2 com-
plexes, these data strongly suggest that recruitment of mals, so it is likely that the FYVE finger in SARA similarly
mediates interaction with the membrane. Furthermore,Smad2 to the receptor containing subcellular domains
is important for TGFb signaling. these domains also contain receptors, so it is reason-
able to suggest that they are membrane vesicles. Thus,
clustering of the TGFb receptor, as previously describedDiscussion
(Henis et al., 1994; Gilboa et al., 1998), may function to
direct the receptor to SARA and the Smad2 substrate.The regulation of the subcellular localization of compo-
Facilitating interactions between the receptor kinasenents of signaling pathways can be key determinants
and its Smad substrate may be most critical in vivo,in the effective initiation and maintenance of signaling
where ser/thr kinase receptors are often found in lowcascades. Targeting the location of signal transduction
numbers and only a small proportion need to be acti-pathways through protein±protein and protein±lipid in-
vated for full biological responses (Dyson and Gurdon,teractions can thus facilitate activation of a pathway
1998).by localizing kinases with their downstream substrates
(Faux and Scott, 1996; Pawson and Scott, 1997; Schaef-
SARA as a Control Point for Smad Activationfer et al., 1998; Whitmarsh et al., 1998). Here, we have
and TGFb Signalingidentified SARA, a protein that binds directly and specifi-
We observed that elevating Smad2 levels can saturatecally to unphosphorylated Smad2 and Smad3. SARA
SARA and yield a diffuse distribution for Smad2. Thus,contains a lipid-binding FYVE domain and functions in
the level of SARA protein is a key determinant in control-TGFb signaling to recruit Smad2 to the TGFb receptor
ling Smad2 localization. As a consequence, endogenousby mediating the specific subcellular localization of
Smad2 may or may not display a SARA-like distribution,Smad and by associating with the TGFb receptor com-
depending on the relative expression of the two pro-plex. Furthermore, inducing mislocalization of Smad2 by
teins. Indeed, in Mv1Lu cells endogenous Smad2 dis-expressing a mutant of SARA blocks TGFb-dependent
plays a punctate pattern with some diffuse staining intranscriptional responses, indicating an important role
the cytosol (this study and Janknecht et al., 1998), andfor SARA-mediated localization of Smads in signaling.
we did not observe complete colocalization with SARA.Together, these results suggest a model (Figure 7E) in
However, once signaling has commenced, Smad2 dis-which SARA is localized to specific subcellular regions
sociates from SARA, binds to Smad4, and translocatesin the cell through interactions between the FYVE do-
to the nucleus, freeing SARA to recruit additional Smad2main and PtdIns(3)P. This in turn leads to recruitment
from the cytosolic reservoir. This would provide a mech-of Smad2 through interactions with the SBD. Once TGFb
anism to allow quantitative activation of Smads in thesignaling is initiated, SARA and Smad2 cooperatively
presence of high levels of TGFb signaling. By functioninginteract with the receptor complex. Upon phosphoryla-
to recruit Smad2 to the TGFb receptor, SARA is locatedtion, Smad2 dissociates, binds to Smad4, and translo-
in an important regulatory position in the pathway. Thus,cates to the nucleus, freeing SARA for further recruit-
control of SARA localization, protein levels, or inter-ment of Smads.
actions with Smad2 could potentially modulate TGFb
signaling. Further, disruption of normal SARA function
Smad Recruitment in TGFb Signaling could potentially be involved in loss of TGFb respon-
The colocalization and association of SARA with the siveness that is a common feature during tumor progres-
TGFb receptor defines a role for SARA in recruiting sion. We are currently mapping the chromosomal loca-
Smad2 to the receptor kinase. Our finding that deletion tion of SARA to explore this latter possibility.
of the FYVE domain interferes with receptor binding,
prevents the correct localization of SARA/Smad2, and SARA Defines a Family of Related Proteins
blocks TGFb signaling suggests that this is an important SARA may define a new class of FYVE domain proteins
function in the pathway. However, binding of SARA to that function to recruit components of signaling cas-
cades to specific regions of the cell. Indeed, in the
Cell
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(amino acids 241±467), and pGEX4T-1-hSARA (amino acids 665±course of this work we identified and cloned two other
750) were constructed by PCR.SARA-like proteins. One of these, from Xenopus, is
closely related to SARA (T. T. et al., unpublished data),
In Vitro Protein Interactionswhile the second one is a human clone, distantly related
In vitro transcription/translation reactions were performed using theto SARA, that was also identified in an EST project (clone
TNT coupled reticulocyte lysate system (Promega) following theKIAA0305). KIAA0305 has a FYVE domain, and compari-
manufacturer's instructions using T3 RNA polymerase. Translation
son of the SBD from SARA with the same region in was carried out in the presence of [35S]methionine, and labeled
KIAA0305 reveals that the amino-terminal half is highly proteins were incubated with purified GST fusion proteins in TNTE
divergent. This suggests that in KIAA0305 this domain buffer with 10% glycerol for 2 hr at 48C and then washed five times
with the same buffer. Bound protein was separated by SDS-PAGEmay anchor other, as yet unidentified proteins, that func-
and visualized by autoradiography.tion either in TGFb or other signaling pathways.
Immunoprecipitation, Immunoblotting, and Affinity LabelingAdditional Roles for SARA
COS-1 cells transfected by LipofectAMINE (GIBCO BRL) were lysed
Controlling the localization of kinases and their sub- with lysis buffer (Wrana et al., 1994) and subjected to immunoprecip-
strates may allow not only for efficient recognition and itation with either anti-Flag M2 (IBI, Eastern Kodak) or anti-Myc
phosphorylation but may also function to maintain spec- (9E10) monoclonal antibody followed by adsorption to protein
G-Sepharose. Precipitates were analyzed by immunoblotting as de-ificity and suppress cross talk between signaling path-
scribed previously (Hoodless et al., 1996). For affinity labeling, trans-ways. Thus, by controlling Smad localization, SARA
fected COS-1 cells were incubated with 200 pM [125I]TGFb in mediacould additionally function to maintain the highly spe-
containing 0.2% bovine fetal serum at 378C for 30 min, and receptors
cific regulation of Smad phosphorylation by ser/thr ki- were cross-linked to ligand with DSS as described previously (Ma-
nase receptors that is observed in vivo and could pre- cõÂas-Silva et al., 1996). Cell lysates were immunoprecipitated with
vent promiscuous phosphorylation by other kinases in anti-Flag antibody, and receptors were visualized by SDS-PAGE
and autoradiography or were quantitated using a gamma counter.the cell. Furthermore, through its interactions with the
TGFb receptor, SARA might function to control the activ-
ity or turnover of the receptor complex. Alternatively, Preparation of Polyclonal Antiserum against hSARA
SARA may also fulfill scaffolding functions to coordinate Rabbit polyclonal antiserum was raised against bacterially produced
GST-hSARA (aa 1011±1172). Antisera was purified using an affinitythe receptor-dependent activation of Smads with other
matrix prepared by coupling GST-hSARA to Hi-Trap NHS-activatedas yet unidentified components of the TGFb signaling
Sepharose (Amersham Pharmacia) by incubating in 0.2 M NaHCO3,pathway.
0.5 M NaCl (pH 8.3) for 2 hr. Antibody was bound to the GST-
hSARA matrix, eluted from the column in 100 mM glycine (pH 2.5),
neutralized in 1 M Tris (pH 8), and dialyzed overnight in phosphate-Experimental Procedures
buffered saline (pH 7.5).
Isolation of Xenopus and Human SARA
For expression library screening, the Smad2 MH2 domain (amino
Subcellular Localization by Immunofluorescent
acids 241±467) was subcloned into a modified pGEX4T-1 vector
Confocal Microscopy
(Pharmacia) containing a protein kinase A recognition site. Bacteri-
Mv1Lu cells, plated on gelatin-coated Permanox chamber slides
ally expressed protein was purified, labeled with [32P]gATP, and used
(Nunc), were transfected by the calcium phosphate-DNA precipita-
as probe to screen a lZAP II Xenopus dorsal lip library (kindly
tion method. Fixation, permealibization, and reaction with the pri-
provided by C. Wright, Vanderbilt) as described (Chen and Sudol,
mary and secondary antibodies were described previously (Hood-
1995). A screen of 1 3 106 plaques yielded four repeated phage
less et al., 1996). Staining of endogenous SARA and Smad2/3 in
isolates encoding a 3.1 kb partial cDNA. A full-length clone was
Mv1Lu cells was as described previously (Janknecht et al., 1998).
obtained by a combination of rescreening of the same dorsal lip
library using a 670 base pair EcoRI/HpaI fragment at the 59 end of
this clone and by 59 RACE (GIBCO BRL) using stage 10 Xenopus Transcriptional Response Assay
RNA. Mv1Lu or HepG2 cells were transiently transfected with CMV-bgal
To obtain a human homolog of Xenopus SARA, cDNA synthesized and the indicated constructs using calcium-phosphate transfection
from randomly primed HepG2 cell total RNA was subjected to PCR as previously described (LabbeÂ et al., 1998). Twenty-four hours after
using degenerate primers as described previously (Attisano et al., transfection, cells were incubated overnight with or without 50 pM
1992). The 59 and 39 primers, designed to encode the zinc-finger TGFb. Luciferase activity was measured using the luciferase assay
motif correspond to GC(A/C/G/T)CC(A/C/G/T)AA(C/T)TG(C/T)ATGA system (Promega) in a Berthold Lumat LB 9501 luminometer and
A(A/C/G/T)TG(C/T) and (A/G)CA(A/G)TA(C/T)TC(A/C/G/T)GC(A/C/G/ was normalized to b-galactosidase activity.
T)GG(A/G)TT (A/G)TT, respectively. The resulting 150 bp PCR prod-
uct was then used as probe for screening a lZAP human fetal brain
AcknowledgmentscDNA library (Stratagene). Eight positive plaques were obtained, two
of which contained an overlap of approximately 1 kb and covered the
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